lobbying_activities: 2686528

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
2686528	4fef0021-a697-4f89-bed3-58762fb26533	Q3	SMITHS GROUP SERVICES CORPORATION	290137	SMITHS GROUP SERVICES CORPORATION	2021	third_quarter	MED	Policies and issues related to medical device technology, including: patient infusion therapy, Medicare reimbursement for opioid alternative treatments, federal COVID response, and medical supply chain shortages; H.R.748, CARES Act (P.L.116-136); S.987, CARA 3.0 Act of 2021; S.586/H.R.3259, NOPAIN Act.	Army, Dept of (Other),Centers For Medicare and Medicaid Services (CMS),Defense, Dept of (DOD),Energy, Dept of,Environmental Protection Agency (EPA),Food & Drug Administration (FDA),Health & Human Services, Dept of (HHS),Homeland Security, Dept of (DHS),HOUSE OF REPRESENTATIVES,Navy, Dept of,SENATE,Transportation Security Administration (TSA),U.S. Customs & Border Protection,White House Office		250000	0	0	2021-10-18T16:27:59.477000-04:00